Schedule of Segment Reporting Information, by Segment |
The following table summarizes segment information for the years ended December 31, 2018, 2017 and 2016 (in thousands). | | | | | | | | | | | | | | | | | | | For the Years Ended December 31, | | | | | | 2018 | | 2017 (as adjusted) | | 2016 (as adjusted) | Net Revenues: | | | | | | Clinical Services | $ | 241,873 | | $ | 213,097 | | $ | 210,159 | Pharma Services | 34,868 | | 27,154 | | 21,649 | Total Revenue | $ | 276,741 | | $ | 240,251 | | $ | 231,808 | Cost of Revenue: | | | | | | Clinical Services | $ | 128,297 | | $ | 121,785 | | $ | 120,437 | Pharma Services | 21,179 | | 16,510 | | 13,267 | Total Cost of Revenue | $ | 149,476 | | $ | 138,295 | | $ | 133,704 | | | | | | | Gross Margin: | | | | | | Clinical Services | $ | 113,576 | | $ | 91,313 | | $ | 89,722 | Pharma Services | 13,689 | | 10,643 | | 8,382 | Total Gross Margin | $ | 127,265 | | $ | 101,956 | | $ | 98,104 |
|